Haemodynamic action of thymoxamine (an alpha-adrenergic blocking agent) in occlusive peripheral arterial disease.
D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D002302:Cardiac Output / Q000187:drug effects; D002986:Clinical Trials as Topic; D005260:Female; D005263:Femoral Artery; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000098:blood supply; D010919:Placebos; D012039:Regional Blood Flow / Q000187:drug effects; D012867:Skin / Q000098:blood supply; D013565:Sympatholytics / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010919:Placebos; D013565:Sympatholytics; D014665:Vasodilator Agents